Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

Paolo Prandoni; Anthonie W. A. Lensing; Martin H. Prins; Martin Gebel; Akos F. Pap; Martin Homering; Rupert Bauersachs; Jan Beyer-Westendorf; Henri Bounameaux; Alexander T. Cohen; Bruce L. Davidson; Bonno van Bellen; Peter Verhamme; Philip S. Wells; Zhong Yuan; Bennett Levitan; Jeffrey I. Weitz

doi:10.1016/j.thromres.2018.06.009

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

Paolo Prandoni, Anthonie W. A. Lensing, Martin H. Prins, Martin Gebel, Akos F. Pap, Martin Homering, Rupert Bauersachs, Jan Beyer-Westendorf, Henri Bounameaux, Alexander T. Cohen, Bruce L. Davidson, Bonno van Bellen, Peter Verhamme, Philip S. Wells, Zhong Yuan, Bennett Levitan, Jeffrey I. Weitz^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	121-129
Number of pages	9
Journal	Thrombosis Research
Volume	168
DOIs	https://doi.org/10.1016/j.thromres.2018.06.009
Publication status	Published - 1 Aug 2018

Keywords

INTENSITY WARFARIN THERAPY
LONG-TERM
NONSURGICAL PATIENTS
ATRIAL-FIBRILLATION
PREVENTION
DISEASE
ANTICOAGULANTS
COMPLICATIONS
DEFINITION
THROMBOSIS

Access to Document

10.1016/j.thromres.2018.06.009

Cite this

Prandoni, P., Lensing, A. W. A., Prins, M. H., Gebel, M., Pap, A. F., Homering, M., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Cohen, A. T., Davidson, B. L., van Bellen, B., Verhamme, P., Wells, P. S., Yuan, Z., Levitan, B., & Weitz, J. I. (2018). Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. Thrombosis Research, 168, 121-129. https://doi.org/10.1016/j.thromres.2018.06.009

Prandoni, Paolo ; Lensing, Anthonie W. A. ; Prins, Martin H. ; Gebel, Martin ; Pap, Akos F. ; Homering, Martin ; Bauersachs, Rupert ; Beyer-Westendorf, Jan ; Bounameaux, Henri ; Cohen, Alexander T. ; Davidson, Bruce L. ; van Bellen, Bonno ; Verhamme, Peter ; Wells, Philip S. ; Yuan, Zhong ; Levitan, Bennett ; Weitz, Jeffrey I. / Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. In: Thrombosis Research. 2018 ; Vol. 168. pp. 121-129.

@article{f34ad43b070040988bcfa38719bb651c,

title = "Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin",

keywords = "INTENSITY WARFARIN THERAPY, LONG-TERM, NONSURGICAL PATIENTS, ATRIAL-FIBRILLATION, PREVENTION, DISEASE, ANTICOAGULANTS, COMPLICATIONS, DEFINITION, THROMBOSIS",

author = "Paolo Prandoni and Lensing, {Anthonie W. A.} and Prins, {Martin H.} and Martin Gebel and Pap, {Akos F.} and Martin Homering and Rupert Bauersachs and Jan Beyer-Westendorf and Henri Bounameaux and Cohen, {Alexander T.} and Davidson, {Bruce L.} and {van Bellen}, Bonno and Peter Verhamme and Wells, {Philip S.} and Zhong Yuan and Bennett Levitan and Weitz, {Jeffrey I.}",

year = "2018",

month = aug,

day = "1",

doi = "10.1016/j.thromres.2018.06.009",

language = "English",

volume = "168",

pages = "121--129",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Science",

}

Prandoni, P, Lensing, AWA, Prins, MH, Gebel, M, Pap, AF, Homering, M, Bauersachs, R, Beyer-Westendorf, J, Bounameaux, H, Cohen, AT, Davidson, BL, van Bellen, B, Verhamme, P, Wells, PS, Yuan, Z, Levitan, B & Weitz, JI 2018, 'Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin', Thrombosis Research, vol. 168, pp. 121-129. https://doi.org/10.1016/j.thromres.2018.06.009

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin. / Prandoni, Paolo; Lensing, Anthonie W. A.; Prins, Martin H.; Gebel, Martin; Pap, Akos F.; Homering, Martin; Bauersachs, Rupert; Beyer-Westendorf, Jan; Bounameaux, Henri; Cohen, Alexander T.; Davidson, Bruce L.; van Bellen, Bonno; Verhamme, Peter; Wells, Philip S.; Yuan, Zhong; Levitan, Bennett; Weitz, Jeffrey I.

In: Thrombosis Research, Vol. 168, 01.08.2018, p. 121-129.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin

AU - Prandoni, Paolo

AU - Lensing, Anthonie W. A.

AU - Prins, Martin H.

AU - Gebel, Martin

AU - Pap, Akos F.

AU - Homering, Martin

AU - Bauersachs, Rupert

AU - Beyer-Westendorf, Jan

AU - Bounameaux, Henri

AU - Cohen, Alexander T.

AU - Davidson, Bruce L.

AU - van Bellen, Bonno

AU - Verhamme, Peter

AU - Wells, Philip S.

AU - Yuan, Zhong

AU - Levitan, Bennett

AU - Weitz, Jeffrey I.

PY - 2018/8/1

Y1 - 2018/8/1

KW - INTENSITY WARFARIN THERAPY

KW - LONG-TERM

KW - NONSURGICAL PATIENTS

KW - ATRIAL-FIBRILLATION

KW - PREVENTION

KW - DISEASE

KW - ANTICOAGULANTS

KW - COMPLICATIONS

KW - DEFINITION

KW - THROMBOSIS

U2 - 10.1016/j.thromres.2018.06.009

DO - 10.1016/j.thromres.2018.06.009

M3 - Article

C2 - 30064683

VL - 168

SP - 121

EP - 129

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

ER -